Jim Simons Catalyst Pharmaceuticals, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,888,427 shares of CPRX stock, worth $28.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,888,427
Previous 1,597,427
18.22%
Holding current value
$28.6 Million
Previous $26.9 Million
12.1%
% of portfolio
0.05%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding CPRX
# of Institutions
278Shares Held
95.7MCall Options Held
40.6KPut Options Held
67.2K-
Black Rock Inc. New York, NY17.7MShares$269 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$138 Million3.01% of portfolio
-
State Street Corp Boston, MA8.15MShares$124 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.98MShares$121 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.74MShares$41.5 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $1.56B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...